| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
AMEX: GNT |
| Security Type |
American Depositary Shares |
| Lead Underwriter |
Maxim Group LLC |
| Days In Registration |
143 |
| Date Filed |
24-Jan-2005 |
| Form Filed | F-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Biotechnology company |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
7.76M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
2.7M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
2.7M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
360.0K |
| File Amount |
$27.0M |
| File Price Range |
$11.00 - $9.00 |
| File Mid Price |
$10.00 |
Current Filing Information
(Amended 7-Apr-2005) |
|
US |
|
Shares Filed |
2.7M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
2.7M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$27.0M |
| · % Change from Original |
0.0 |
| File Price Range |
$11.00 - $9.00 |
| File Mid Price |
$10.00 |
|
